These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33349241)

  • 1. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study.
    Gong J; Dong H; Xia QS; Huang ZY; Wang DK; Zhao Y; Liu WH; Tu SH; Zhang MM; Wang Q; Lu FE
    BMC Infect Dis; 2020 Dec; 20(1):963. PubMed ID: 33349241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
    Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
    Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
    Wang D; Li R; Wang J; Jiang Q; Gao C; Yang J; Ge L; Hu Q
    BMC Infect Dis; 2020 Jul; 20(1):519. PubMed ID: 32677918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum inflammatory parameters and the disease severity in COVID-19 patients.
    Mardani R; Namavar M; Ghorbi E; Shoja Z; Zali F; Kaghazian H; Aghasadeghi MR; Sadeghi SA; Sabeti S; Darazam IA; Ahmadi N; Mousavi-Nasab SD
    J Clin Lab Anal; 2022 Jan; 36(1):e24162. PubMed ID: 34874079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
    Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
    Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.
    Xu Y; Wang N; Shen X; Liu X; Liu H; Liu Y
    Clin Exp Med; 2023 Nov; 23(7):3719-3728. PubMed ID: 37310657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity.
    da Silva-Neto PV; de Carvalho JCS; Pimentel VE; Pérez MM; Toro DM; Fraga-Silva TFC; Fuzo CA; Oliveira CNS; Rodrigues LC; Argolo JGM; Carmona-Garcia I; Neto NT; Souza COS; Fernandes TM; Bastos VAF; Degiovani AM; Constant LF; Ostini FM; Feitosa MR; Parra RS; Vilar FC; Gaspar GG; da Rocha JJR; Feres O; Frantz FG; Gerlach RF; Maruyama SR; Russo EMS; Viana AL; Fernandes APM; Santos IKFM; Bonato VLD; Boechat AL; Malheiro A; Sadikot RT; Dias-Baruffi M; Cardoso CRB; Faccioli LH; Sorgi CA; On Behalf Of The Imunocovid Study Group
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019.
    Zhong Y; Cao Y; Zhong X; Peng Z; Jiang S; Tang T; Chen H; Li X; Xia Y; Cheng Y; Zhao X
    Am J Obstet Gynecol; 2021 Apr; 224(4):393.e1-393.e25. PubMed ID: 33098813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between early inflammation indicators and the severity of coronavirus disease 2019].
    Li Y; Lin S; Zhou Y; Pan J; Chen Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):145-149. PubMed ID: 33729130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine laboratory testing to determine if a patient has COVID-19.
    Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity.
    Tang Y; Sun J; Pan H; Yao F; Yuan Y; Zeng M; Ye G; Yang G; Zheng B; Fan J; Pan Y; Zhao Z; Guo S; Liu Y; Liao F; Duan Y; Jiao X; Li Y
    Cytokine; 2021 Jul; 143():155523. PubMed ID: 33840589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Predictive Value of Interleukin-6 and Neutrophil-Lymphocyte Ratio in Patients with Severe and Extremely Severe Oral and Maxillofacial Space Infections.
    Xiaojie L; Hui L; Zhongcheng G; Chenggang W; Yaqi N
    Biomed Res Int; 2021; 2021():2615059. PubMed ID: 33575324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.
    Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X
    Front Immunol; 2021; 12():626235. PubMed ID: 33584733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between Serum Inflammatory Factor Levels and Differentiated Thyroid Carcinoma.
    Zhang X; Li S; Wang J; Liu F; Zhao Y
    Technol Cancer Res Treat; 2021; 20():1533033821990055. PubMed ID: 33752541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of clinical parameters in predicting the severity of COVID-19.
    Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
    J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulatory Cytokine Levels as a Predictor of Disease Severity in COVID-19: A Study from Western India.
    Bhandari S; Rankawat G; Mathur S; Kumar A; Sahlot R; Jain A
    J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.